Format

Send to

Choose Destination
J Neurol. 2019 Jan;266(1):92-101. doi: 10.1007/s00415-018-9084-4. Epub 2018 Oct 31.

Progressive myoclonus epilepsy in Gaucher Disease due to a new Gly-Gly mutation causing loss of an Exonic Splicing Enhancer.

Author information

1
Clinic of Paediatric Neurology and Laboratories, A.O.U Meyer, Viale Pieraccini n.24, 50139, Florence, Italy.
2
Department of NEUROFARBA, University of Florence, Florence, Italy.
3
Metabolic Unit, A.O.U Meyer, Florence, Italy.
4
Clinic of Paediatric Neurology and Laboratories, A.O.U Meyer, Viale Pieraccini n.24, 50139, Florence, Italy. amelia.morrone@meyer.it.
5
Department of NEUROFARBA, University of Florence, Florence, Italy. amelia.morrone@meyer.it.

Abstract

BACKGROUND:

Patients with Gaucher Disease (GD) exhibit three phenotypes, including type 1 (non-neuronopathic), type 2 (acute neuronopathic), and type 3 (subacute neuronopathic).

AIM:

Identifying which GBA changes represent benign polymorphisms and which may result in disease-causing mutations is essential for diagnosis and genotype/phenotype correlations but is often challenging.

RESULTS:

Here, we describe a patient with type 3 GD, presenting with drug-resistant epilepsy, who bears a set of GBA polymorphic variants including the novel c.363A > G (Gly82Gly) synonymous mutation. In silico predictions, mRNA and functional studies revealed that the new Gly82Gly mutation causes skipping of GBA exon 4, leading to a severe reduction of the wild type GBA mRNA. This is the first report of a synonymous change causing GD through loss of an exonic splicing enhancer sequence. The synonymous mutation is in trans with the Asn188Ser missense mutation, thus making the Asn188Ser responsible for the patient's phenotype and strengthening the association of Asn188Ser with the particular neurological phenotype of type 3 GD.

CONCLUSION:

We strengthen the association of Asn188Ser with the type 3 GD phenotype and progressive myoclonus epilepsy. Our data confirm that in silico predictions and mRNA analysis are mandatory in discriminating pathological mutations from the background of harmless polymorphisms, especially synonymous changes.

KEYWORDS:

Exon skipping; Exonic splicing enhancer; GBA gene; Gaucher Disease; Progressive myoclonic epilepsy; Synonymous mutation

PMID:
30382391
PMCID:
PMC6342868
DOI:
10.1007/s00415-018-9084-4
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center